Pushpa Pharmaceuticals Private Limited
About Pushpa Pharmaceuticals Private Limited
Data last updated:
Pushpa Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 21 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24230UP2020PTC133015.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amit Kumar Sharma and Arun Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C3/203 Vikrant Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010.
As per the financials filed for FY 2023, the company reported a revenue of ₹3.24 Lakh, a decline of 66% compared to the previous year. For the same year it recorded a net loss of ₹44,664 (net margin -13.8%) and EBITDA of -₹44,664 (EBITDA margin -13.8%).
Company details
Contact details
Pushpa Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh.
- Registered AddressC3/203 Vikrant Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pushpa Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Pushpa Pharmaceuticals Private Limited, buy the company report.
Financials of Pushpa Pharmaceuticals Private Limited
FY 2023 filings availablePushpa Pharmaceuticals Private Limited reported revenue of ₹3.24 Lakh (down 66% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 66% in the latest year. EBITDA fell 762% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹44,664 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹44,664 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -13.8% | ||
| Net Profit Margin | -13.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Pushpa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Pushpa Pharmaceuticals Private Limited
Pushpa Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Kumar Sharma | Director | 21 Aug 2020 | 6 Years 2 Months | Current |
| Arun Srivastava | Additional Director | 02 Apr 2024 | 2 Years 6 Months | Current |
Peer comparison
Pushpa Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| N.C. Pharmaceuticals Private Limited | ₹3.27 Lakh (FY 2017) | New Delhi, Delhi, India | ||||
| Medineeds Pharmaceuticals Private Limited | ₹3.25 Lakh (FY 2019) | Ranchi, Jharkhand, India | ||||
| Pushpa Pharmaceuticals Private Limitedthis company | ₹3.24 Lakh (FY 2023) | -₹44,664 | -13.8% | -66.0% | Lucknow, Uttar Pradesh, India | |
| Fysan Pharmaceuticals Private Limited | ₹3.22 Lakh (FY 2020) | -62.0% | Pune, Maharashtra, India | |||
| Prickom Pharmaceuticals Private Limited | ₹3.22 Lakh (FY 2025) | 34.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Pushpa Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pushpa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pushpa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Pushpa Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Pushpa Pharmaceuticals Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Arun Srivastava was appointed as Additional Director on 02 Apr 2024.
Frequently asked questions
Pushpa Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 21 August 2020 (6+ years old) and is registered under CIN U24230UP2020PTC133015.
Pushpa Pharmaceuticals has 2 current directors:
- Amit Kumar Sharma - Director
- Arun Srivastava - Additional Director
The latest financial statements of Pushpa Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Pushpa Pharmaceuticals is U24230UP2020PTC133015. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pushpa Pharmaceuticals was incorporated on 21 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Pushpa Pharmaceuticals by revenue are N.C. Pharmaceuticals Private Limited, Medineeds Pharmaceuticals Private Limited, Fysan Pharmaceuticals Private Limited, Prickom Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Arun Srivastava was appointed as Additional Director on 02 Apr 2024. Sandhya Rai ceased to be Director on 02 Apr 2024. Amit Kumar Sharma was appointed as Director on 21 Aug 2020. Pushpa Pharmaceuticals has 4 board changes on record in total.
The registered office of Pushpa Pharmaceuticals is at C3203 Vikrant Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010.
Pushpa Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Pushpa Pharmaceuticals can be reached at its registered office: C3203 Vikrant Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010.
Pushpa Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.